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Summary
Background:  Advantages  of  one-stage  bilateral  total  hip  arthroplasty  (THA)  include  a  single  hos-
pital stay,  a  shorter  rehabilitation  time,  and  decreased  management  costs  per  patient.  However,
concern about  a  possible  increase  in  the  perioperative  complication  rate  has  limited  the  use
of this  strategy.  Here,  our  objectives  were  to  evaluate  morbidity  and  mortality,  as  well  as
functional outcomes,  in  patients  managed  with  one-stage  bilateral  THA.
Hypothesis:  The  complication  rate  after  one-stage  bilateral  THA  is  not  signiﬁcantly  different
from that  after  unilateral  THA.
Materials  and  methods:  Four  French  surgical  centres  participated  in  a  retrospective  observa-
tional study  of  patients  managed  with  one-stage  bilateral  THA.  The  112  included  patients  (55
women) had  a  mean  age  of  59  years  (range,  22—84)  and  a  mean  follow-up  of  30  months  (6—103).
Results: Mean  hospital  stay  length  was  10.8  days  (6—27),  mean  operative  time  was  162  minutes
(95—270),  and  mean  haemoglobin  levels  were  14.3  g/dL  preoperatively  and  10.1  g/dL  post-
operatively.  No  perioperative  deaths  were  recorded.  Deep  vein  thrombosis  occurred  in  eight
(7.1%) patients  and  pulmonary  embolism  in  six  (5.4%).  The  Merle  d’Aubigné  score  improved  from
9.25 ±  2.9  (3—16)  preoperatively  to  17.5  ±  1  (14—18)  at  last  follow-up.  All  but  three  patients
(109/112,  97%)  said  they  would  choose  the  same  operation  again  and  102/112  (91%)  said  they
would recommend  it  to  a  family  member.
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Discussion:  The  results  of  this  multicentre  retrospective  study  indicate  that  one-stage  bilateral
THA is  a  valid  alternative  to  two-stage  bilateral  THA  in  ASA  1  and  2  patients  with  a  preoperative
haemoglobin  level  of  about  14  g/L.  The  major  complication  rate  was  7.1%,  which  was  slightly
higher than  after  unilateral  THA,  and  the  main  complications  were  deep  vein  thrombosis  and
pulmonary  embolism.
Level  of  evidence:  Level  IV  (multicentre  retrospective  observational  study).
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room.  All  patients  had  a  suction  drain  placed  in  each  hip  and
received  prophylactic  antibiotic  therapy,  as  well  as  throm-
boembolism  prevention  with  low-molecular-weight  heparin
for  30  days.
The  statistical  analysis  relied  on  the  non-parametric
Fisher  exact  test.  P  value  inferior  to  0.05  was  considered
signiﬁcant.© 2012  Published  by  Elsevie
Introduction
The  beneﬁts  of  total  hip  arthroplasty  (THA)  have  been  abun-
dantly  documented  [1,2]. However,  10%  of  patients  require
contralateral  THA  within  1  year  after  their  ﬁrst  THA  pro-
cedure  [3].  In  addition,  optimal  functional  outcomes  are
obtained  only  after  bilateral  THA  [4].  One-stage  bilateral
THA  (1bi-THA)  has  several  advantages  including  a  single
hospital  stay,  a  shorter  rehabilitation  time  [5],  and  lower
management  costs  per  patient  [6].  Concern  about  a  pos-
sible  increase  in  perioperative  complications  after  1bi-THA
and,  in  France,  the  absence  of  a  dedicated  Diagnosis-Related
Group  in  the  nationwide  hospital  database  and  the  statutory
health  insurance  system  policy  of  reimbursing  only  75%  of
the  cost  of  the  second  procedure  have  limited  the  use  of
1bi-THA.
Here,  our  working  hypothesis  was  that  1bi-THA,  in
appropriately  selected  patients,  was  a  valid  alternative  to
two-stage  bilateral  THA.  The  two  main  study  objectives
were  to  evaluate  the  morbidity  and  mortality  rates  and  to
measure  the  functional  outcomes  after  1bi-THA.
Materials and methods
Four  French  surgical  centres  were  invited  to  participate
in  an  observational  retrospective  study  of  patients  man-
aged  with  1bi-THA.  For  each  patient,  the  following  data
were  collected:  hospital  stay  length;  operative  time;  preop-
erative  and  postoperative  haemoglobin  levels;  homologous
blood  transfusions;  vital  status;  and  complications  includ-
ing  pulmonary  embolism,  surgical  site  infection,  dislocation,
revision,  leg  length  discrepancy,  and  other  intraoperative
and  postoperative  complications.  Doppler  ultrasonography
was  performed  routinely  after  surgery.  Functional  outcomes
were  assessed  using  the  Postel-Merle  d’Aubigné  (PMA)  score
[7]  before  surgery,  6  months  after  surgery,  and  at  last  follow-
up.  An  anteroposterior  pelvic  radiograph  and  two  Lequesne
false-proﬁle  radiographs  were  obtained  preoperatively  and
postoperatively  (Fig.  1).  A  subjective  evaluation  was  per-
formed  by  asking  the  patients  whether  they  would  be  willing
to  undergo  the  same  procedure  again  and  whether  they
would  recommend  it  to  a  family  member.
We  included  patients  in  American  Society  of  Anesthesi-
ologists  (ASA)  [8]  categories  1,  2,  and  3  who  had  bilateral
hip  disease  with  no  evidence  of  infection.  Exclusion  criteria
were  a  history  of  hip  fusion,  ASA  category  4  or  greater,  and
revision  surgery.Of the  112  included  patients,  42  were  ASA  1,  63  ASA  2,
and  seven  ASA  3.  The  male/female  ratio  was  1  (57/55).  Mean
age  was  59  years  (range,  22—84).  The  initial  diagnosis  was
hip  osteoarthritis  in  77  patients,  avascular  necrosis  of  the
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emoral  head  in  24,  rapidly  destructive  hip  disease  in  six,
equelae  of  congenital  hip  dysplasia  in  three,  and  rheuma-
oid  arthritis  in  two.  The  posterolateral  approach  was  used
n  all  patients.  The  two  hip  replacements  were  performed
equentially  by  the  same  surgical  team,  with  the  same  main
perator.  General  anaesthesia  was  used  in  41  patients,  spinal
naesthesia  in  23,  epidural  anaesthesia  in  15,  and  combined
eneral  and  epidural  anaesthesia  in  33.  At  the  end  of  the  pro-
edure,  a  pelvic  radiograph  was  obtained  in  the  operatingigure  1  Anteroposterior  pelvic  radiograph:  rapidly  destruc-
ive hip  disease  (A)  and  appearance  3  years  after  one-stage
ilateral  total  hip  replacement  (B).
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[igure  2  Evolution  of  haemoglobin  rate  and  peri-operative
ata  regarding  transfusion.
esults
ean  follow-up  was  30  months  (range,  6—103),  mean  hospi-
al  stay  length  was  10.8  days  (6—27),  and  mean  operative
ime  was  162  minutes  (95—270).  Mean  haemoglobin  lev-
ls  were  14.3  g/dL  (13.1—15.9  g/dL)  preoperatively  and
0.1  g/dL  postoperatively  (7.6—11.5  g/dL).  Fig.  2  describes
he  blood-sparing  strategy.
No  perioperative  deaths  were  recorded.  Table  1  lists  the
omplications.  Doppler  ultrasonography  showed  deep  vein
Table  1  Complications  after  one-stage  bilateral  total  hip
arthroplasty.
Major  8/112  (7.1%)
Death  0
Pulmonary  embolism  6  (5.4%)
Myocardial  infarction  0
Deep-seated  infection  1
Stroke 0
Revision  surgery  for  implant  loosening  1
Minor 19/112  (17%)
Hematoma  2
Deep vein  thrombosis  8  (7.1%)
Urinary  tract  infection  3
Pressure  sore  2
Dislocation  1
Re-operation  for  piriformis  syndrome  1
Heterotopic  ossiﬁcations  1
Ilio-psoas  irritation  1
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hrombosis  in  eight  patients  (7.1%)  and  pulmonary  embolism
as  conﬁrmed  by  contrast-enhanced  computed  tomography
n  six  (5.4%)  patients,  including  two  ASA  3  patients  with
evere  symptoms.
Of the  seven  ASA  3  patients,  three  (42.8%)  experienced
eep  vein  thrombosis  with  pulmonary  embolism,  compared
o  ﬁve  (4.7%)  with  deep  vein  thrombosis  and  three  (2.8%)
ith  pulmonary  embolism  among  the  105  ASA  1/2  patients
P  <  0.006).  No  signiﬁcant  differences  in  complication  rates
ere  found  across  reasons  for  THA  (hip  osteoarthritis
s.  other)  or  anaesthesia  techniques  (general  anaesthesia,
pinal  anaesthesia,  epidural  anaesthesia,  or  combined  gen-
ral  and  epidural  anaesthesia).
The  PMA  score  improved  from  9.25  ±  2.9  (3—16)  pre-
peratively  to  17.5  ±  1  (14—18)  at  last  follow-up.  All  but
hree  patients  (109/112,  97%)  said  they  would  be  willing
o  undergo  the  same  procedure  again  and  102/112  (91%)
aid  they  would  recommend  the  procedure  to  someone
lse.
iscussion
his  multicentre  retrospective  case-series  study  establishes
bi-THA  as  a  valid  alternative  to  two-stage  bilateral  THA,
ince  the  safety  proﬁle  was  good  in  our  population  of
elected  patients  [9].  The  risk  of  major  complications  did
ot  seem  increased  with  1bi-THA,  despite  continuing  contro-
ersy  about  the  pulmonary  embolism  rate  and  relative  risk  of
eath  associated  with  this  procedure  [10—13]. Berend  et  al.
11]  reported  a  higher  pulmonary  embolism  rate  among  450
atients  managed  with  1bi-THA,  but  their  comparison  group
as  composed  of  patients  who  underwent  unilateral  THA
nd  not  two-stage  bilateral  THA.  Saito  et  al.  [13]  and  Kim
t  al.  [12]  found  no  increase  in  complication  rates  with  1bi-
HA  compared  to  two-stage  bilateral  THA.  Aghaev  et  al.
13]  even  reported  fewer  complications  with  the  one-stage
rocedure.  In  our  study,  the  main  complications  were  deep
ein  thrombosis  and  pulmonary  embolism.  These  are  the  two
ost  common  complications  after  all  forms  of  THA  (unilat-
ral  THA,  two-stage  bilateral  THA,  and  1bi-THA)  [14,15].
o  deaths  occurred  in  our  population  of  selected  patients.
mong  previous  studies,  some  found  an  increase  in  the  rela-
ive  risk  of  death  after  1bi-THA  compared  to  unilateral  THA
14,16],  but  another  did  not  [12]. The  risk  of  death  after
bi-THA  may  not  be  higher  than  the  cumulative  risk  of  death
ssociated  with  two-stage  bilateral  THA  [15,17]. Our  results
nd  those  reported  in  the  literature  indicate  that  1bi-THA
hould  be  reserved  for  ASA  1/2  patients:  the  complication
ate  is  unacceptably  high  in  ASA  3  patients,  who  have  a
hree-fold  higher  relative  risk  of  death.
Our  work  emphasises  the  crucial  importance  of  the  blood-
paring  strategy.  The  most  recent  studies  consistently  found
igniﬁcant  increases  in  homologous  blood  transfusion  rates
fter  1bi-THA,  of  20  to  40%  [12,14—16].  Measures  that
hould  keep  the  homologous  blood  transfusion  rate  below
0%  include  preoperative  erythropoietin  treatment  and  iron
upplementation  to  increase  the  haemoglobin  level,  use
f  a  cell-saver  with  immediate  reinfusion  of  autologous
lood,  and  postoperative  erythropoietin  and  iron  therapy  to
nsure  compensation  of  the  intraoperative  blood  loss.  Fur-
hermore,  autologous  blood  transfusion  in  the  immediate
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postoperative  period  is  associated  with  a  signiﬁcant
decrease  in  the  need  for  homologous  blood  transfusion
[18].
Our  study  conﬁrms  the  excellent  functional  outcomes
after  1bi-THA  [5,11,17],  in  keeping  with  data  reported
by  Charnley  and  Jaffé  as  early  as  1971  [5].  A  recent
study  of  a  European  registry  [17]  showed  better  functional
outcomes  after  1bi-THA  compared  to  two-stage  bilateral
THA.  Patient  satisfaction  is  an  important  parameter,  and
97%  of  our  patients  said  they  would  be  willing  to  repeat
the  same  procedure.  Thus,  in  patients  who  have  no  con-
traindications  related  to  an  unacceptably  high  surgical  risk,
1bi-THA  deserves  consideration  in  two  situations,  namely,
incapacitating  bilateral  hip  disease  with  normal  hip  posi-
tion  and  hip  disease  with  bilateral  abnormalities  in  hip
position.  In  patients  who  have  incapacitating  bilateral  hip
disease  with  normal  hip  position,  1bi-THA  optimises  the
functional  outcomes  [4],  shortens  the  rehabilitation  time
[5],  and  decreases  the  cost  of  management  [6].  There-
fore,  1bi-THA  deserves  consideration  in  this  situation  as
an  alternative  to  two-stage  bilateral  THA.  In  patients  who
have  bilateral  abnormalities  in  hip  position,  most  notably
ﬂexion  contractures  greater  than  20◦,  1bi-THA  is  highly
desirable,  as  persistence  of  the  ﬂexion  contracture  on
the  unoperated  side  after  unilateral  THA  precludes  the
resumption  of  walking  and  adversely  affects  the  operated
hip.  Finally,  given  the  cost-saving  nature  of  1bi-THA  [3,6],
reasonable  measures  would  consist  in  creating  a  speciﬁc
Diagnosis-Related  Group  for  1bi-THA  and  increasing  the
reimbursement  of  the  second  replacement  from  the  current
75%  to  100%.
Conclusion
Although  our  study  has  a  number  of  methodological  weak-
nesses  including  the  multi-surgeon  retrospective  design,
absence  of  a  control  group,  absence  of  a  cost  evaluation,
and  small  sample  size,  our  results  support  the  use  of  1bi-THA
in  carefully  selected  patients.  Thus,  1bi-THA  is  a  valid  alter-
native  to  two-stage  bilateral  THA  in  ASA  1/2  patients  whose
preoperative  haemoglobin  level  is  greater  than  14  g/dL.  The
main  complications  are  deep  vein  thrombosis  and  pulmonary
embolism.
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